[Intensive anticancer chemotherapy. Transfusion of autologous bone marrow. Rooms exempt of pathogenic germs].
G Mathé, A. FLAISLER(Institut Gustave Roussy), M. Schneider(Institut Gustave Roussy), Jeanne Amiel(Hôpital Necker-Enfants Malades), L Schwarzenberg(Institut Gustave Roussy), A Cattan, Jean Schlumberger
PubMed
November 26, 1966
Cited by 6
Related Papers
Successful Allogenic Bone Marrow Transplantation in Man: Chimerism, Induced Specific Tolerance and Possible Anti-Leukemic Effects
|Blood|1965|165
SLC10A7 mutations cause a skeletal dysplasia with amelogenesis imperfecta mediated by GAG biosynthesis defects
|Nature Communications|2018|70
Loss of function mutations in GEMIN5 cause a neurodevelopmental disorder
|Nature Communications|2021|52
Activating variants in <scp><i>PDGFRB</i></scp> result in a spectrum of disorders responsive to imatinib monotherapy
|American Journal of Medical Genetics Part A|2020|34
De novo and biallelic DEAF1 variants cause a phenotypic spectrum
|Genetics in Medicine|2019|33